Exact Sciences Corp [NASDAQ: EXAS] price surged by 3.33 percent to reach at $1.52.
The one-year EXAS stock forecast points to a potential upside of 29.92. The average equity rating for EXAS stock is currently 1.40, trading closer to a bullish pattern in the stock market.
Guru’s Opinion on Exact Sciences Corp [EXAS]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for EXAS shares is $67.29 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on EXAS stock is a recommendation set at 1.40. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Mizuho have made an estimate for Exact Sciences Corp shares, keeping their opinion on the stock as Outperform, with their previous recommendation back on April 10, 2025. While these analysts kept the previous recommendation, RBC Capital Mkts raised their target price to Sector Perform. The new note on the price target was released on March 13, 2025, representing the official price target for Exact Sciences Corp stock. Previously, the target price had yet another raise to $70, while Barclays analysts kept a Overweight rating on EXAS stock.
The Average True Range (ATR) for Exact Sciences Corp is set at 2.21, with the Price to Sales ratio for EXAS stock in the period of the last 12 months amounting to 3.18. The Price to Book ratio for the last quarter was 3.64, with the Price to Cash per share for the same quarter was set at 5.59. Price to Free Cash Flow for EXAS in the course of the last twelve months was 117.51 with Quick ratio for the last quarter at 1.92.
EXAS Stock Performance Analysis:
Exact Sciences Corp [EXAS] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 3.42. With this latest performance, EXAS shares gained by 8.54% in over the last four-week period, additionally sinking by -32.00% over the last 6 months – not to mention a drop of -19.77% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for EXAS stock in for the last two-week period is set at 58.28, with the RSI for the last a single of trading hit 64.84, and the three-weeks RSI is set at 54.05 for Exact Sciences Corp [EXAS]. The present Moving Average for the last 50 days of trading for this stock 45.44, while it was recorded at 45.73 for the last single week of trading, and 55.78 for the last 200 days.
Insight into Exact Sciences Corp Fundamentals:
Exact Sciences Corp’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.92 and a Current Ratio set at 2.15.
Exact Sciences Corp [EXAS] Institutonal Ownership Details
There are presently around $98.84%, or 99.72%% of EXAS stock, in the hands of institutional investors. The top three institutional holders of EXAS stocks are: VANGUARD GROUP INC with ownership of 18.18 million shares, which is approximately 9.8611%. CAPITAL WORLD INVESTORS, holding 16.5 million shares of the stock with an approximate value of $$697.18 million in EXAS stocks shares; and CAPITAL WORLD INVESTORS, currently with $$624.81 million in EXAS stock with ownership which is approximately 8.0235%.
